Stereo Vision Entertainment Inc. (PINK:SVSN) reached up 193.33% in morning trading to $.088 with 600K shares traded. Stereo Vision Entertainment is a publicly traded company whose business is driven by the acquisition, development, production and distribution of cutting edge 3D media assets. Responding to the current exponential growth of demand for 3D content, Stereo Vision is developing a wide variety of 3D technologies and intellectual properties for these rapidly expanding markets. Stereo Vision Entertainment Inc. (Pinksheets: SVSN.PK - News) announced today the signing of an exclusive worldwide license agreement for Stereo 3D technology that will reduce 3D bandwidth and storage requirements by an average of 40% to 60% with no loss of resolution.
Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) reached up 24.43% in morning trading to $1.63 with 1M shares traded. Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials for the treatment of cancer and serious viral infections. The company is pursuing multiple clinical programs in cancer and hepatitis C virus infection with its lead product candidate bavituximab and novel brain cancer agent Cotara®. Peregrine also has in-house cGMP manufacturing capabilities through its wholly-owned subsidiary Avid Bioservices, Inc. (www.avidbio.com), which provides development and biomanufacturing services for both Peregrine and outside customers. Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM - News) today announced 20.7 month median overall survival (OS) from a prior single-arm Phase II trial evaluating bavituximab in combination with docetaxel in patients with locally advanced or metastatic breast cancer. In a separate published study(1) included in the docetaxel package insert, median OS was 11.7 months for metastatic breast cancer patients treated with docetaxel alone. Currently, Peregrine's bavituximab is being evaluated in randomized Phase II trials in non-small cell lung cancer (NSCLC), pancreatic cancer, and hepatitis C virus (HCV), as well as in four investigator-sponsored trials (ISTs) in additional oncology indications, including HER2-negative metastatic breast cancer.
Diamond Discoveries International Corp. (OTCQB: DMDD) reached up 14.40% in morning trading to $.0143 with 1M shares traded. Diamond Discoveries International Corp. is a U.S. exploration company with executive offices in New York, NY and Burlington, Ontario. Since inception it has been focused on diamonds, chromium, PGE (platinum, palladium and rhodium) and gold. In June of 2008 the company received a NI 43-101 technical report on its 100% owned Caribou Property, Thetford Mines, Quebec. Diamond Discoveries International Corp. (OTCQB: DMDD) announced that it has resumed its exploration program commenced in 2008 that resulted in high chromium values in multiple areas.
For a detailed quote on any of the following companies, or to read the full news articles visit PennyTrader.com
About PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.
Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report
PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to CLICK HERE
